Rezultati pretrage - Geert Jan Groeneveld
- Prikaz rezultata 1 – 20 od 24
- Idi na sljedeću stranicu
-
1
-
2
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Pharmacodynamic Effects of VX-150, a Highly Selective NaV1.8 Inhibitor, in Healthy Male Adu... od Hemme J. Hijma, Pieter Siebenga, Marieke L. de Kam, Geert Jan Groeneveld
Izdano 2021Artigo -
3
-
4
-
5
-
6
Lack of Detection of the Analgesic Properties of PF‐05089771, a Selective Na<sub>v</sub>1.7 Inhibitor, Using a Battery of Pain Models in Healthy Subjects od Pieter Siebenga, Guido van Amerongen, Justin L. Hay, Aoibhinn McDonnell, Donal Gorman, Richard P. Butt, Geert Jan Groeneveld
Izdano 2019Artigo -
7
EEG machine learning for accurate detection of cholinergic intervention and Alzheimer’s disease od Sonja Simpraga, Ricardo Álvarez-Jiménez, Huibert D. Mansvelder, Joop van Gerven, Geert Jan Groeneveld, Simon-Shlomo Poil, Klaus Linkenkaer‐Hansen
Izdano 2017Artigo -
8
-
9
-
10
Acute Effects of Riluzole and Retigabine on Axonal Excitability in Patients With Amyotrophic Lateral Sclerosis: A Randomized, Double‐Blind, Placebo‐Controlled, Crossover Trial od Maria O. Kovalchuk, Jules A. A. C. Heuberger, Boudewijn T.H.M. Sleutjes, Dimitrios Ziagkos, Leonard H. van den Berg, Toby A. Ferguson, Hessel Franssen, Geert Jan Groeneveld
Izdano 2018Artigo -
11
Tolerance to Opioid‐Induced Respiratory Depression in Chronic High‐Dose Opioid Users: A Model‐Based Comparison With Opioid‐Naïve Individuals od Marijke Hyke Algera, Erik Olofsen, Laurence Moss, Robert L. Dobbins, Marieke Niesters, Monique van Velzen, Geert Jan Groeneveld, Jules A. A. C. Heuberger, Céline M. Laffont, Albert Dahan
Izdano 2020Artigo -
12
-
13
Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis od Jan H. Veldink, Sandra Kalmijn, Geert Jan Groeneveld, Wendy Wunderink, Annemarie Koster, J.H.M. de Vries, Jolanda van der Luyt, John H. J. Wokke, Leonard H. van den Berg
Izdano 2006Artigo -
14
A Phase <scp>1B</scp> Trial in <i><scp>GBA1</scp>‐</i>Associated Parkinson's Disease of BIA‐28‐6156, a Glucocerebrosidase Activator od Jonas M. den Heijer, Annelieke C. Kruithof, Matthijs Moerland, Mike Walker, Lindsay Dudgeon, Craig Justman, Imelda Solomini, Leslie Splitalny, Nancy Leymarie, Kshitij Khatri, Valerie Cullen, Dana Hilt, Geert Jan Groeneveld, Peter T. Lansbury
Izdano 2023Artigo -
15
Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-tetrahydrocannabinol in Patients With Progressive Multiple Sclerosis od Guido van Amerongen, Kawita M. S. Kanhai, Anne Catrien Baakman, Jules A. A. C. Heuberger, Erica S. Klaassen, Tim L. Beumer, R.L.M. Strijers, Joep Killestein, Joop van Gerven, Adam F. Cohen, Geert Jan Groeneveld
Izdano 2017Artigo -
16
<scp>DNL</scp>104, a Centrally Penetrant <scp>RIPK</scp>1 Inhibitor, Inhibits <scp>RIP</scp>1 Kinase Phosphorylation in a Randomized Phase I Ascending Dose Study in Healthy Volunte... od Hendrika W. Grievink, Jules A. A. C. Heuberger, Fen Huang, Rinkal Chaudhary, Willem Birkhoff, George Tonn, Sofia Mosesova, Rebecca Erickson, Matthijs Moerland, Patrick C. G. Haddick, Kimberly Scearce‐Levie, Carole Ho, Geert Jan Groeneveld
Izdano 2019Artigo -
17
Effect of sustained high buprenorphine plasma concentrations on fentanyl-induced respiratory depression: A placebo-controlled crossover study in healthy volunteers and opioid-toler... od Laurence Moss, Marijke Hyke Algera, Robert L. Dobbins, Frank Gray, Stephanie Strafford, Amy Heath, Monique van Velzen, Jules A. A. C. Heuberger, Marieke Niesters, Erik Olofsen, Céline M. Laffont, Albert Dahan, Geert Jan Groeneveld
Izdano 2022Artigo -
18
A Biomarker Study in Patients with <i>GBA1</i> ‐Parkinson's Disease and Healthy Controls od Jonas M. den Heijer, Valerie Cullen, D. Pereira, Yalçin Yavuz, Marieke L. de Kam, Hendrika W. Grievink, Matthijs Moerland, Nancy Leymarie, Kshitij Khatri, Imelda Sollomoni, Leslie Spitalny, Lindsay Dungeon, Dana Hilt, Craig Justman, Peter T. Lansbury, Geert Jan Groeneveld
Izdano 2023Artigo -
19
A randomized single and multiple ascending dose study in healthy volunteers of LTI‐291, a centrally penetrant glucocerebrosidase activator od Jonas M. den Heijer, Annelieke C. Kruithof, Guido van Amerongen, Marieke L. de Kam, Eva Thijssen, Hendrika W. Grievink, Matthijs Moerland, Mike Walker, Kees Been, Renato T. Skerlj, Craig Justman, Lindsay Dudgeon, Peter T. Lansbury, Valerie Cullen, Dana Hilt, Geert Jan Groeneveld
Izdano 2021Artigo -
20
Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trial od Pepijn Eijsvogel, Pinaki Misra, Luis Concha‐Marambio, Justin D. Boyd, Shuang Ding, Lauren Fedor, Yueh-Ting Hsieh, Yu Sun, Madeline M. Vroom, Carly M. Farris, Yihua Ma, Marieke L. de Kam, Igor Radanović, Maurits F. J. M. Vissers, Dario Mirski, Ghazal Shareghi, Mohammad Shahnawaz, Wolfgang Singer, Philip H. C. Kremer, Geert Jan Groeneveld, Hui Jing Yu, Jean‐Cosme Dodart
Izdano 2024Artigo
Alati za pretragu:
Povezani predmeti
Medicine
Internal medicine
Pathology
Alternative medicine
Placebo
Disease
Pharmacology
Anesthesia
Adverse effect
Biochemistry
Chemistry
Pharmacokinetics
Receptor
Crossover study
Environmental health
Parkinson's disease
Pharmacodynamics
Population
Tolerability
Amyotrophic lateral sclerosis
Biology
Biomarker
Clinical trial
Immunology
Oncology
Randomized controlled trial
Antibody
Computer science
Double blind
Engineering